Michael Andriola
Neurology · Clearwater, FLNPI 1144279985
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,222 and has fallen 78.2% since, to $267 in 2025.
Across 252 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$790
- Acadia Pharmaceuticals Inc$786
- UCB, Inc.$378
- GE HealthCare$283
- Neurocrine Biosciences, Inc.$232
- Abbott$187
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$1063%
- Food & beverage$4,07997%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $790 |
| Acadia Pharmaceuticals Inc | 58 | $786 |
| UCB, Inc. | 22 | $378 |
| GE HealthCare | 14 | $283 |
| Neurocrine Biosciences, Inc. | 15 | $232 |
| Abbott | 6 | $187 |
| Adamas Pharmaceuticals, Inc. | 9 | $170 |
| Teva Pharmaceuticals USA, Inc. | 15 | $156 |
| Acorda Therapeutics, Inc | 9 | $154 |
| Kyowa Kirin, Inc. | 7 | $120 |
| Sanofi | 5 | $107 |
| Sunovion Pharmaceuticals Inc. | 5 | $103 |
| MDD US Operations, LLC | 6 | $83 |
| Johnson & Johnson | 5 | $69 |
| Biogen | 3 | $64 |
| Biohaven Pharmaceuticals, Inc. | 4 | $61 |
| Lundbeck LLC | 3 | $61 |
| Portola Pharmaceuticals, LLC | 3 | $60 |
| Amneal Pharmaceuticals LLC | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Amgen | 2 | $36 |
| Lilly USA, LLC | 2 | $31 |
| Novartis | 2 | $30 |
| Boston Scientific | 1 | $27 |
| AstraZeneca | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| CSL Behring | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,187 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.
Other neurology in Clearwater
- Jean-Raphael SchneiderClearwater$219K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.